<div class="white-sheet">
    <div class="content-slide">


        <div class="title-bar red"></div>

		<div class="wrapper slide-2-9-1">


			<div class="popups" style="position:absolute">
				<div data-effect="fade" data-duration="1000" data-target="references-overlay" data-width="600" data-height="490" class="references-button show-overlay"></div>
                <div data-effect="fade" data-duration="1000" data-target="information-overlay" data-width="600" data-height="490" class="information-button show-overlay"></div>		
			</div>

			<div class="slide-title red two-line">
				Quality-adjusted survival analysis: bone<br /> marrow transplant versus immunosuppressive therapy 
			</div>


			<div class="content-container" style="overflow-y: scroll;-webkit-overflow-scrolling: touch;">
				
				<table class="red">
					<tr>
                        <th>Parameter</th>
                        <th style="text-align:center">BMT</th>
                        <th style="text-align:center">IST</th>
						<th style="text-align:center"><i>p</i>-value</th>
					</tr>

					<tr class="odd">
						<td style="font-weight:bold">Survival (%)</td>
                        <td></td>
                        <td></td>
                        <td></td>
					</tr>

					<tr>
						<td>15-year overall survival</td>
                        <td style="text-align:center">51+15%</td>
                        <td style="text-align:center">53+10%</td>
                        <td style="text-align:center">0.20</td>
					</tr>

					<tr class="odd">
						<td>15-year event free survival</td>
                        <td style="text-align:center">25+14%</td>
                        <td style="text-align:center">27+8%</td>
                        <td style="text-align:center">0.12</td>
					</tr>

                    <tr>
                        <td>Duration of health state (years)</td>
                        <td></td>
                        <td></td>
                        <td></td>
                    </tr>

                    <tr class="odd">
                        <td>Treatment-related toxicity</td>
                        <td style="text-align:center">0.27</td>
                        <td style="text-align:center">0.36</td>
                        <td style="text-align:center">&lt;0.001</td>
                    </tr>

                     <tr>
                        <td>Transfusion dependency </td>
                        <td style="text-align:center">0.1</td>
                        <td style="text-align:center">0.66</td>
                        <td style="text-align:center">&lt;0.001</td>
                    </tr>

                    <tr class="odd">
                        <td>Partial remission</td>
                        <td style="text-align:center">1.42</td>
                        <td style="text-align:center">3.27</td>
                        <td style="text-align:center">=0.001</td>
                    </tr>

                     <tr>
                        <td>Secondary clonal disorders</td>
                        <td style="text-align:center">0.04</td>
                        <td style="text-align:center">0.68</td>
                        <td style="text-align:center">&lt;0.001</td>
                    </tr>

                    <tr class="odd">
                        <td>Complete remission without medication</td>
                        <td style="text-align:center">1.21</td>
                        <td style="text-align:center">1.60</td>
                        <td style="text-align:center">0.431</td>
                    </tr>

                     <tr>
                        <td>Extensive chronic GVHD</td>
                        <td style="text-align:center">0.96</td>
                        <td style="text-align:center">0</td>
                        <td style="text-align:center">=0.023</td>
                    </tr>

                    <tr class="odd">
                        <td style="font-weight:bold">Cause of death (%)</td>
                        <td></td>
                        <td></td>
                        <td></td>
                    </tr>

                     <tr>
                        <td>Treatment-related</td>
                        <td style="text-align:center">46</td>
                        <td style="text-align:center">13</td>
                        <td style="text-align:center">0.003</td>
                    </tr>

                    <tr class="odd">
                        <td>Disease-related</td>
                        <td style="text-align:center">33</td>
                        <td style="text-align:center">41</td>
                        <td style="text-align:center">0.686</td>
                    </tr>

                    <tr>
                        <td>MDS or leukaemia</td>
                        <td style="text-align:center">0</td>
                        <td style="text-align:center">13</td>
                        <td style="text-align:center">0.024</td>
                    </tr>

                    <tr class="odd">
                        <td>PNH</td>
                        <td style="text-align:center">0</td>
                        <td style="text-align:center">2</td>
                        <td style="text-align:center">0.024</td>
                    </tr>

                    <tr>
                        <td>Relapse of aplastic anaemia</td>
                        <td style="text-align:center">0</td>
                        <td style="text-align:center">9</td>
                        <td style="text-align:center">0.024</td>
                    </tr>


				</table>

			</div>

		</div>


        <div class="information-overlay overlay">
            
            <header>Quality-adjusted survival analysis: bone marrow transplant versus immunosuppressive therapy</header>

            <ul>
                <li><span>A retrospective, single-centre study was conducted to compare survival and quality of life outcomes (from 1976 to 1999) between aplastic anaemia patients treated with BMT and those treated with IST</span></li>
                <li><span>Survival, event-free survival and Q-TWIST (quality adjusted time without symptoms or toxicity) for both groups were compared</span></li>
                <li><span>Overall responses or event-free survival rates were similar for both therapies</span>
                    <ul>
                        <li><span>However, treatment-related deaths were significantly higher with BMT compared with IST </span></li>
                    </ul>
                </li>
                <li><span>BMT-treated patients experienced a shorter duration of treatment-related toxicity and longer time in complete remission without medication compared with IST-treated patients; however, this was not statistically significant</span>
                    <ul>
                        <li><span>IST-treated patients require closer medical care, transfusion support and medications</span></li>
                    </ul>
                </li>
                <li><span>Published literature on the cost aspects of severe aplastic anaemia is limited, especially in adults </span></li>
            </ul>
            
          

        </div>


		<div class="references-overlay overlay">

			<header>References</header>
				
			<ul>
                <li class="navigateHref" data-navtarget="media/documents/module2/ViollierR-2005-AnnHematol-v84p47.pdf"><span>Viollier R <i>et al. Ann Haematol</i> 2005;84:47</span></li>
			</ul>

		</div>


          
   


    </div>
 </div>